Related Experiment Video
Updated: May 12, 2026

Fluorescence Microscopy for ATP Internalization Mediated by Macropinocytosis in Human Tumor Cells and Tumor-xenografted Mice
Published on: June 30, 2021
Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers
M Sánchez-Aragó1, L Formentini, I Martínez-Reyes
1Departamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Instituto de Investigación Hospital 12 de Octubre, Universidad Autónoma de Madrid, Madrid, Spain.
Abstract:
Recent findings in colon cancer cells indicate that inhibition of the mitochondrial H(+)-adenosine triphosphate (ATP) synthase by the ATPase inhibitory factor 1 (IF1) promotes aerobic glycolysis and a reactive oxygen species (ROS)-mediated signal that enhances proliferation and cell survival. Herein, we have studied the expression, biological relevance, mechanism of regulation and potential clinical impact of IF1 in some prevalent human carcinomas. We show that IF1 is highly overexpressed in most (>90%) of the colon (n=64), lung (n=30), breast (n=129) and ovarian (n=10) carcinomas studied as assessed by different approaches in independent cohorts of cancer patients. The expression of IF1 in the corresponding normal tissues is negligible. By contrast, the endometrium, stomach and kidney show high expression of IF1 in the normal tissue revealing subtle differences by carcinogenesis. The overexpression of IF1 also promotes the activation of aerobic glycolysis and a concurrent ROS signal in mitochondria of the lung, breast and ovarian cancer cells mimicking the activity of oligomycin. IF1-mediated ROS signaling activates cell-type specific adaptive responses aimed at preventing death in these cell lines. Remarkably, regulation of IF1 expression in the colon, lung, breast and ovarian carcinomas is exerted at post-transcriptional levels. We demonstrate that IF1 is a short-lived protein (t1/2 ∼100 min) strongly implicating translation and/or protein stabilization as main drivers of metabolic reprogramming and cell survival in these human cancers. Analysis of tumor expression of IF1 in cohorts of breast and colon cancer patients revealed its relevance as a predictive marker for clinical outcome, emphasizing the high potential of IF1 as therapeutic target.
Insights
The ATPase inhibitory factor 1 (IF1) is overexpressed in most human carcinomas, promoting cancer cell survival and proliferation through aerobic glycolysis and reactive oxygen species (ROS) signaling. IF1 shows potential as a predictive marker and therapeutic target in cancer.
Area of Science:
- Mitochondrial physiology
- Cancer biology
- Metabolic reprogramming
Background:
- Inhibition of mitochondrial H(+)-adenosine triphosphate (ATP) synthase by ATPase inhibitory factor 1 (IF1) in colon cancer cells promotes aerobic glycolysis and reactive oxygen species (ROS) signaling, enhancing proliferation and survival.
- Understanding IF1's role in various human carcinomas is crucial for identifying new therapeutic targets.
Purpose of the Study:
- To investigate the expression, biological relevance, regulatory mechanisms, and clinical impact of IF1 in prevalent human carcinomas.
- To explore IF1's role in metabolic reprogramming and cell survival across different cancer types.
Main Methods:
- Analysis of IF1 expression in patient cohorts of colon, lung, breast, and ovarian carcinomas using various approaches.
- Assessment of IF1's impact on aerobic glycolysis and ROS signaling in cancer cell lines.
- Determination of IF1 protein half-life and investigation of post-transcriptional regulation.
- Correlation of tumor IF1 expression with clinical outcomes in breast and colon cancer patients.
Main Results:
- IF1 is highly overexpressed (>90%) in colon, lung, breast, and ovarian carcinomas, with negligible expression in corresponding normal tissues.
- IF1 overexpression activates aerobic glycolysis and ROS signaling in lung, breast, and ovarian cancer cells, mimicking oligomycin effects.
- IF1-mediated ROS signaling triggers adaptive responses to prevent cell death.
- IF1 expression is regulated at post-transcriptional levels, with a short protein half-life (∼100 min) suggesting translational control or protein stabilization.
- Tumor IF1 expression serves as a predictive marker for clinical outcome in breast and colon cancer patients.
Conclusions:
- IF1 is a significantly overexpressed protein in major human carcinomas, playing a critical role in promoting cancer cell survival and proliferation.
- Post-transcriptional regulation and protein stability are key drivers of IF1's function in metabolic reprogramming and survival.
- IF1 represents a promising therapeutic target and a valuable predictive biomarker for cancer patient outcomes.
Related Concept Videos
ATP Synthase: Mechanism
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Regulation of Angiogenesis and Blood Supply
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
ATP Synthase: Structure

